Ibrutinib (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ibrutinib (low-dose), covering 2022-04-27 to 2022-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease [Phase 2]